Ayşe Boyvat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ayşe Boyvat has a total of 262 co-authors. Here are the top co-authors by number of shared publications:
Aynur Akyol
7 shared publications- Aylin Okcu Heper
Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey
6 shared publications - Bengü Nisa Akay
Ankara University Faculty of Medicine Department of Dermatology Ankara Turkey
6 shared publications Erbak Gürgey
From the Ankara University School of Medicine, Department of Dermatology and Pathology, Ankara, Turkey
6 shared publications- Pelin Kocyigit
Department of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey
5 shared publications Aysel Gurler
Ufuk University
4 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Danylo Halytskyi Lviv National Medical University in Lviv clinical bulletin
- No. 3 (55),p. 69-72
From Vasculitis to Vasculopathy: A Rare Overlap of H. Behçet Disease and Livedoid Vasculopathy
Introduction. Behçet disease (BD) is a multisystemic, variable-vessel vasculitis first described by H. Behçet in 1937. Livedoid vasculopathy (LV) is a chronic, painful, thrombo-occlusive vasculopathy characterized by recurrent ulcerations and microthrombosis of dermal vessels. The aim of the study. To report a rare overlap of livedoid vasculopathy and Behçet disease, highlighting this uncommon association and discussing its clinical manifestations and therapeutic implications. The coexistence of behçet disease and livedoid vasculopathy is exceedingly rare, with only a single pediatric case reported in the literature to date. Materials and methods. Herein, we report the first adult case of concomitant BD and LV. A 42-year-old woman with a 4-year history of BD presented with painful, non-healing ulcers on both ankles persisting for eight months, accompanied by prominent burning sensations. Previous treatment with systemic corticosteroids resulted in no clinical improvement. Histopathological examination of a skin biopsy revealed features consistent with livedoid vasculopathy. Antithrombotic therapy with enoxaparin and aspirin led to rapid and marked clinical improvement. Results. To the best of our knowledge, this is the second reported case of BD associated with LV and the first described in an adult patient. Recognition of this rare coexistence is crucial, as LV-directed antithrombotic therapy may be essential for achieving clinical remission in BD patients presenting with refractory ulcerative lesions. Consclusion. Awareness of this rare association is important, as early recognition and appropriate antithrombotic therapy can significantly improve clinical outcome.
- 30 September 2026
- Published by Danylo Halytskyi Lviv National Medical University in Lviv clinical bulletin
- No. 3 (55),p. 69-72
Open AccessFrom Vasculitis to Vasculopathy: A Rare Overlap of H. Behçet Disease and Livedoid Vasculopathy
Introduction. Behçet disease (BD) is a multisystemic, variable-vessel vasculitis first described by H. Behçet in 1937. Livedoid vasculopathy (LV) is a chronic, painful, thrombo-occlusive vasculopathy characterized by recurrent ulcerations and microthrombosis of dermal vessels. The aim of the study. To report a rare overlap of livedoid vasculopathy and Behçet disease, highlighting this uncommon association and discussing its clinical manifestations and therapeutic implications. The coexistence of behçet disease and livedoid vasculopathy is exceedingly rare, with only a single pediatric case reported in the literature to date. Materials and methods. Herein, we report the first adult case of concomitant BD and LV. A 42-year-old woman with a 4-year history of BD presented with painful, non-healing ulcers on both ankles persisting for eight months, accompanied by prominent burning sensations. Previous treatment with systemic corticosteroids resulted in no clinical improvement. Histopathological examination of a skin biopsy revealed features consistent with livedoid vasculopathy. Antithrombotic therapy with enoxaparin and aspirin led to rapid and marked clinical improvement. Results. To the best of our knowledge, this is the second reported case of BD associated with LV and the first described in an adult patient. Recognition of this rare coexistence is crucial, as LV-directed antithrombotic therapy may be essential for achieving clinical remission in BD patients presenting with refractory ulcerative lesions. Consclusion. Awareness of this rare association is important, as early recognition and appropriate antithrombotic therapy can significantly improve clinical outcome.
- 12 March 2025
- Published by Springer Nature
- p. 99-111
Systemic Treatments for Mucocutaneous Behçet’s Disease
- 12 March 2025
- Published by Springer Nature
- p. 99-111
Systemic Treatments for Mucocutaneous Behçet’s Disease
- 12 March 2025
- Published by Springer Nature
- p. 211-218
How Should We Diagnose Behçet’s Disease
- 12 March 2025
- Published by Springer Nature
- p. 75-81
Specificity of Papulopustular Lesions in the Diagnosis of Behçet’s Disease
- 12 March 2025
- Published by Springer Nature
- p. 75-81
Specificity of Papulopustular Lesions in the Diagnosis of Behçet’s Disease
- Open Access
- 15 October 2023
- Published by Wiley in Contact Dermatitis
- Vol. 90 (2) , 110-115
Increased rates of contact allergy to selected preservatives in patients with allergic contact dermatitis in Turkey
Background: Preservatives are a frequent cause of allergic contact dermatitis (ACD) and have caused numerous epidemics.Objectives: The objective of this study is to determine the prevalence of preservative sensitivity, assess the change in the frequency of sensitivity, identify new preservatives with increased sensitivity rates, and evaluate the situation in Turkey by comparing our findings with current literature.Methods: A total of 201 patients diagnosed with ACD between 2018 and 2020, were patch tested with the European baseline series and additional seven preservative haptens. The change in the prevalence of sensitivity to each preservative hapten was investigated by comparing the data from the study conducted in our department between 2000 and 2004.Results: Results showed that 17.4% (n = 35) of the patients were positive to preservatives. Comparison with previous data from 2000 to 2004 revealed an increase in the frequency of sensitization. The most prevalent allergen was methyldibromo glutaronitrile (9.5%), followed by methylchloroisothiazolinone/methylisothiazolinone (6.5%), and methylisothiazolinone (5%).Conclusion: The increase in preservative sensitivity in Turkey is the most remarkable finding. Although MDBGN was prohibited in cosmetic products, MCI/MI and MI are still widely used. Our findings suggest that awareness of preservative sensitivity should be increased and additional precautions should be taken, also in Turkey, regarding the use of preservatives.
- 15 October 2023
- Published by Wiley in Contact Dermatitis
- Vol. 90 (2) , 110-115
Open AccessIncreased rates of contact allergy to selected preservatives in patients with allergic contact dermatitis in Turkey
Background: Preservatives are a frequent cause of allergic contact dermatitis (ACD) and have caused numerous epidemics.Objectives: The objective of this study is to determine the prevalence of preservative sensitivity, assess the change in the frequency of sensitivity, identify new preservatives with increased sensitivity rates, and evaluate the situation in Turkey by comparing our findings with current literature.Methods: A total of 201 patients diagnosed with ACD between 2018 and 2020, were patch tested with the European baseline series and additional seven preservative haptens. The change in the prevalence of sensitivity to each preservative hapten was investigated by comparing the data from the study conducted in our department between 2000 and 2004.Results: Results showed that 17.4% (n = 35) of the patients were positive to preservatives. Comparison with previous data from 2000 to 2004 revealed an increase in the frequency of sensitization. The most prevalent allergen was methyldibromo glutaronitrile (9.5%), followed by methylchloroisothiazolinone/methylisothiazolinone (6.5%), and methylisothiazolinone (5%).Conclusion: The increase in preservative sensitivity in Turkey is the most remarkable finding. Although MDBGN was prohibited in cosmetic products, MCI/MI and MI are still widely used. Our findings suggest that awareness of preservative sensitivity should be increased and additional precautions should be taken, also in Turkey, regarding the use of preservatives.
- 1 March 2022
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 75 (1) , 84-90
Evaluation of HLA Class II Alleles in Cases with Chronic Spontaneous Urticaria
- 1 March 2022
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 75 (1) , 84-90
Evaluation of HLA Class II Alleles in Cases with Chronic Spontaneous Urticaria
- 4 September 2021
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (4) , 2046-2054
Prognostic factors for relapse and poor outcome in neuro-Behçet’s syndrome: results from a clinical long-term follow-up of a single centre
Objective To describe the clinical characteristics of neuro-Behçet’s syndrome (NBS) and to define the factors associated with relapses and poor outcome. Methods Among 2118 patients with Behçet’s syndrome who fulfilled the international study group criteria, 208 (9.8%) patients had NBS. Retrospective data of 125 NBS patients (55.5% male; mean age 37.2 ± 11.8 years) were analysed. We divided patients into two subgroups, either parenchymal (p-NBS) or non-parenchymal (np-NBS), according to international consensus recommendations for NBS. We assessed the predictor factors associated with relapse and poor outcome—which was defined as a modified Rankin score (mRS) ≥ 3 at last follow-up and/or death—using Cox and logistic regression analyses, respectively. Results In total, 79 (63.2%) patients presented with p-NBS and 46 (36.8%) presented with np-NBS. Ocular involvement was more common in p-NBS than np-NBS (55.7% vs. 37.0%, p = 0.04), whereas vascular involvement excluding cerebral vein thrombosis was more frequent in patients with np-NBS (19.0% vs. 52.2%, p < 0.001). Forty-two patients (33.6%) experienced at least one relapse. Factors associated with relapse were BS diagnosis at a younger age and cranial nerve dysfunction (HR 0.96 95% CI 0.93–0.99 and 2.36 95% CI 1.23–4.52, respectively). After a median of 68 (Q1–Q3: 25–125) months, 23 patients (18.4%) had a poor outcome. Indicators of a poor outcome were higher initial mRS and the progressive p-NBS type (OR 8.28 95% CI 1.04–66.20 and 33.57 95% CI 5.99–188.21, respectively). Conclusion Our findings indicate that clinical characteristics and prognosis differ between NBS subgroups, of which patients with p-NBS have worse outcomes.
- 4 September 2021
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (4) , 2046-2054
Prognostic factors for relapse and poor outcome in neuro-Behçet’s syndrome: results from a clinical long-term follow-up of a single centre
Objective To describe the clinical characteristics of neuro-Behçet’s syndrome (NBS) and to define the factors associated with relapses and poor outcome. Methods Among 2118 patients with Behçet’s syndrome who fulfilled the international study group criteria, 208 (9.8%) patients had NBS. Retrospective data of 125 NBS patients (55.5% male; mean age 37.2 ± 11.8 years) were analysed. We divided patients into two subgroups, either parenchymal (p-NBS) or non-parenchymal (np-NBS), according to international consensus recommendations for NBS. We assessed the predictor factors associated with relapse and poor outcome—which was defined as a modified Rankin score (mRS) ≥ 3 at last follow-up and/or death—using Cox and logistic regression analyses, respectively. Results In total, 79 (63.2%) patients presented with p-NBS and 46 (36.8%) presented with np-NBS. Ocular involvement was more common in p-NBS than np-NBS (55.7% vs. 37.0%, p = 0.04), whereas vascular involvement excluding cerebral vein thrombosis was more frequent in patients with np-NBS (19.0% vs. 52.2%, p < 0.001). Forty-two patients (33.6%) experienced at least one relapse. Factors associated with relapse were BS diagnosis at a younger age and cranial nerve dysfunction (HR 0.96 95% CI 0.93–0.99 and 2.36 95% CI 1.23–4.52, respectively). After a median of 68 (Q1–Q3: 25–125) months, 23 patients (18.4%) had a poor outcome. Indicators of a poor outcome were higher initial mRS and the progressive p-NBS type (OR 8.28 95% CI 1.04–66.20 and 33.57 95% CI 5.99–188.21, respectively). Conclusion Our findings indicate that clinical characteristics and prognosis differ between NBS subgroups, of which patients with p-NBS have worse outcomes.
- 27 August 2021
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 51 (4) , 243-245
Systematized Epidermal Nevus Syndrome Involving the Upper and Lower Eyelids Bilaterally
- 27 August 2021
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 51 (4) , 243-245
Systematized Epidermal Nevus Syndrome Involving the Upper and Lower Eyelids Bilaterally
- Open Access
- 1 January 2021
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 33 (4) , 388-389
A Case Report of Pathergy-Like Reaction in a Patient with Behçet's Disease Triggered by Wax Epilation
Boyvat A, et al. Ann Dermatol. 2021 Aug;33(4):388-389. https://doi.org/10.5021/ad.2021.33.4.388
- 1 January 2021
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 33 (4) , 388-389
Open AccessA Case Report of Pathergy-Like Reaction in a Patient with Behçet's Disease Triggered by Wax Epilation
Boyvat A, et al. Ann Dermatol. 2021 Aug;33(4):388-389. https://doi.org/10.5021/ad.2021.33.4.388
- 27 September 2020
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (12) , 1403-1410
Moderation analysis exploring associations between age and mucocutaneous activity in Behçet’s syndrome: A multicenter study from Turkey
The aim of the present study was to examine the effects of age on mucocutaneous activity by using moderation analysis in Behçet’s syndrome (BS). In this cross‐sectional study, 887 BS patients (female : male, 481:406; mean age, 38.4 ± 10.9 years) followed in 13 tertiary centers in Turkey were included. Mucocutaneous activity was evaluated by using the Mucocutaneous Index (MI) according to sex and disease course. Moderation analysis was performed to test the effect of age on mucocutaneous activity. A moderator variable is a third variable and affects the relationship between independent and outcome variables. Age was chosen as a potential moderator variable (interaction effect), MI score as the outcome variable and sex as an independent variable in the analysis. The moderation analysis tested the effects of age in three steps: whole BS patient group, patients without systemic involvement and those with systemic involvement. The moderation model was only significant in BS patients with systemic involvement (P = 0.0351), and a significant relationship was observed between female sex and MI score (P = 0.0156). In addition, the interaction plot showed that female patients had increased MI scores compared with male patients, especially in the 28‐year‐old age group (P = 0.0067). Moreover, major organ involvement was newly diagnosed in the majority of these young female BS patients. Our results suggest that the relationship between sex and mucocutaneous activity was moderated by age in the systemic involvement group. Also, increased mucocutaneous activity may be associated with new major organ involvement in young female BS patients with systemic involvement.
- 27 September 2020
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (12) , 1403-1410
Moderation analysis exploring associations between age and mucocutaneous activity in Behçet’s syndrome: A multicenter study from Turkey
The aim of the present study was to examine the effects of age on mucocutaneous activity by using moderation analysis in Behçet’s syndrome (BS). In this cross‐sectional study, 887 BS patients (female : male, 481:406; mean age, 38.4 ± 10.9 years) followed in 13 tertiary centers in Turkey were included. Mucocutaneous activity was evaluated by using the Mucocutaneous Index (MI) according to sex and disease course. Moderation analysis was performed to test the effect of age on mucocutaneous activity. A moderator variable is a third variable and affects the relationship between independent and outcome variables. Age was chosen as a potential moderator variable (interaction effect), MI score as the outcome variable and sex as an independent variable in the analysis. The moderation analysis tested the effects of age in three steps: whole BS patient group, patients without systemic involvement and those with systemic involvement. The moderation model was only significant in BS patients with systemic involvement (P = 0.0351), and a significant relationship was observed between female sex and MI score (P = 0.0156). In addition, the interaction plot showed that female patients had increased MI scores compared with male patients, especially in the 28‐year‐old age group (P = 0.0067). Moreover, major organ involvement was newly diagnosed in the majority of these young female BS patients. Our results suggest that the relationship between sex and mucocutaneous activity was moderated by age in the systemic involvement group. Also, increased mucocutaneous activity may be associated with new major organ involvement in young female BS patients with systemic involvement.